Gaucher Association Logo

Promoting awareness, pioneering research and providing support and information for those affected by Gaucher disease.


Telephone: 01453 549231

In the News

  • Listen NOW! If you missed first WebEx

    6 June 2013

    Following on from the success of The Associations first ever WebEx event, very kindly presented by Professor Timothy Cox on the recently announce national research study to predict clinical outcomes and responses to treatment in Gaucher …

    read more »

  • ABPI ruling regarding Shire press release

    24 May 2013

    In June 2012 Shire issued a press release with the results of a head to head trial between VPRIV (Shire Human Genetics) and Cerezyme (Genzyme-Sanofi) and the effect that each had on Gaucher related bone disease.

    In August 2012, we posted the …

    read more »

  • Book your WebEx NOW!

    13 May 2013

    The Gauchers Association are pleased to announce they are holding their first WebEx on Monday 20th May at 7.30pm, hosted by Professor Timothy Cox. To register for this event click here

    read more »

  • Empathy Forum

    10 May 2013

    We have been asked to share the details of a up and coming project involving all young patients and the European Patients Forum (EPF).  We should like to encourage all young people to participate where possible and feel the Gaucher community …

    read more »

  • 2012 Alan Gordon Memorial Award

    22 March 2013

    The Gauchers Association is pleased to announce the winner of the 2012 Alan Gordon Memorial Award to the Lysosomal Storage Disorder Clinical Nurse Specialist Team at Great Ormond Street Hospital for their work in supporting the Type III girls …

    read more »

  • Rare Disease Day

    4 March 2013

    The Gauchers Association was pleased to be invited to take part in the publication entitled Rare Diseases distributed within The Independent newspaper on 28th February 2013, in the hope of raising awareness on Rare Disease day.

    Please find …

    read more »

  • Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease

    19 February 2013

    CAMBRIDGE, Mass. – Genzyme, a Sanofi company, announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1. The results from the ENGAGE study were …

    read more »

  • Seasonal Greetings and Christmas opening hours

    19 December 2012

    The Gauchers Association would like to take this opportunity of wishing you Seasonal Greetings and very best wishes for 2013.  We should also like to inform you that the office will be closing from 4pm on Friday 21st December and will …

    read more »

  • Product Alert for Gaucher Patients and Families

    14 December 2012

    Dear all,

    We have been alerted to the existence of another pharmaceutical product called Zavesca that is causing some confusion amongst Gaucher patients throughout the world.  The product, whose packaging is almost identical to that of …

    read more »

  • Gaucher Disease scoops Medical Research Grant

    13 December 2012

    In December 2011, the Medical Research Council (MRC) announced a £60m four-year investment in a Stratified Medicine initiative. Professor Timothy Cox along with the UK eight specialist LSD centres submitted an application and we are …

    read more »